269 related articles for article (PubMed ID: 11640912)
1. Mechanisms of prion-induced modifications in membrane transport properties: implications for signal transduction and neurotoxicity.
Kourie JI
Chem Biol Interact; 2001 Oct; 138(1):1-26. PubMed ID: 11640912
[TBL] [Abstract][Full Text] [Related]
2. Copper modulation of ion channels of PrP[106-126] mutant prion peptide fragments.
Kourie JI; Kenna BL; Tew D; Jobling MF; Curtain CC; Masters CL; Barnham KJ; Cappai R
J Membr Biol; 2003 May; 193(1):35-45. PubMed ID: 12879164
[TBL] [Abstract][Full Text] [Related]
3. Prion protein and metal interaction: physiological and pathological implications.
Singh N; Das D; Singh A; Mohan ML
Curr Issues Mol Biol; 2010; 12(2):99-107. PubMed ID: 19767653
[TBL] [Abstract][Full Text] [Related]
4. The role of prion peptide structure and aggregation in toxicity and membrane binding.
Rymer DL; Good TA
J Neurochem; 2000 Dec; 75(6):2536-45. PubMed ID: 11080207
[TBL] [Abstract][Full Text] [Related]
5. A neurotoxic and gliotrophic fragment of the prion protein increases plasma membrane microviscosity.
Salmona M; Forloni G; Diomede L; Algeri M; De Gioia L; Angeretti N; Giaccone G; Tagliavini F; Bugiani O
Neurobiol Dis; 1997; 4(1):47-57. PubMed ID: 9258911
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human prion protein fragment 90-231, a useful model to study prion neurotoxicity.
Corsaro A; Thellung S; Villa V; Nizzari M; Aceto A; Florio T
OMICS; 2012; 16(1-2):50-9. PubMed ID: 22321015
[TBL] [Abstract][Full Text] [Related]
7. Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides.
Soto C; Kascsak RJ; Saborío GP; Aucouturier P; Wisniewski T; Prelli F; Kascsak R; Mendez E; Harris DA; Ironside J; Tagliavini F; Carp RI; Frangione B
Lancet; 2000 Jan; 355(9199):192-7. PubMed ID: 10675119
[TBL] [Abstract][Full Text] [Related]
8. Prion peptide 106-126 as a model for prion replication and neurotoxicity.
Singh N; Gu Y; Bose S; Kalepu S; Mishra RS; Verghese S
Front Biosci; 2002 Apr; 7():a60-71. PubMed ID: 11897566
[TBL] [Abstract][Full Text] [Related]
9. Prion channel proteins and their role in vacuolation and neurodegenerative diseases.
Kourie JI
Eur Biophys J; 2002 Sep; 31(5):409-16. PubMed ID: 12202918
[TBL] [Abstract][Full Text] [Related]
10. Is PrP(106-126) fragment involved in the membrane activity of the Prion protein?
Henriques ST; Castanho MA
Curr Protein Pept Sci; 2010 Aug; 11(5):326-33. PubMed ID: 20423298
[TBL] [Abstract][Full Text] [Related]
11. Prion protein modulates cellular iron uptake: a novel function with implications for prion disease pathogenesis.
Singh A; Mohan ML; Isaac AO; Luo X; Petrak J; Vyoral D; Singh N
PLoS One; 2009; 4(2):e4468. PubMed ID: 19212444
[TBL] [Abstract][Full Text] [Related]
12. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
[TBL] [Abstract][Full Text] [Related]
13. Amino acid sequence and prion strain specific effects on the in vitro and in vivo convertibility of ovine/murine and bovine/murine prion protein chimeras.
Kupfer L; Eiden M; Buschmann A; Groschup MH
Biochim Biophys Acta; 2007 Jun; 1772(6):704-13. PubMed ID: 17145171
[TBL] [Abstract][Full Text] [Related]
14. Biochemical Characterization of Prions.
Fiorini M; Bongianni M; Monaco S; Zanusso G
Prog Mol Biol Transl Sci; 2017; 150():389-407. PubMed ID: 28838671
[TBL] [Abstract][Full Text] [Related]
15. X-ray diffraction analysis of scrapie prion: intermediate and folded structures in a peptide containing two putative alpha-helices.
Inouye H; Kirschner DA
J Mol Biol; 1997 May; 268(2):375-89. PubMed ID: 9159477
[TBL] [Abstract][Full Text] [Related]
16. Intracellular mechanisms mediating the neuronal death and astrogliosis induced by the prion protein fragment 106-126.
Thellung S; Florio T; Corsaro A; Arena S; Merlino M; Salmona M; Tagliavini F; Bugiani O; Forloni G; Schettini G
Int J Dev Neurosci; 2000; 18(4-5):481-92. PubMed ID: 10817932
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the PrPc Amino-Terminal Domain in Prion Species Barriers.
Davenport KA; Henderson DM; Mathiason CK; Hoover EA
J Virol; 2016 Dec; 90(23):10752-10761. PubMed ID: 27654299
[TBL] [Abstract][Full Text] [Related]
18. Generating Bona Fide Mammalian Prions with Internal Deletions.
Munoz-Montesino C; Sizun C; Moudjou M; Herzog L; Reine F; Chapuis J; Ciric D; Igel-Egalon A; Laude H; Béringue V; Rezaei H; Dron M
J Virol; 2016 Aug; 90(15):6963-6975. PubMed ID: 27226369
[TBL] [Abstract][Full Text] [Related]
19. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
[TBL] [Abstract][Full Text] [Related]
20. Involvement of trace elements in the pathogenesis of prion diseases.
Mizuno D; Koyama H; Ohkawara S; Sadakane Y; Kawahara M
Curr Pharm Biotechnol; 2014; 15(11):1049-57. PubMed ID: 25373386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]